Intranasal Insulin Transiently Improves Early Neurological Deficits and Alters Oxytocin-Related Gene Expression After Mild Hypoxic-Ischemic Brain Injury in Mice
摘要
Hypoxia may occur during general anesthesia and is associated with cerebral ischemia and postoperative cognitive decline. Although intranasal insulin (INI) can alleviate mild hypoxic cerebral injury, its potential for therapeutic application remains underexplored. In this study, we aimed to investigate the effects and changes in INI-induced gene expression in mouse models of cerebral hypoxic-ischemic injury.
MethodsBrain injury was induced in 8–10-week-old male C57BL/6 mice via a combination of left common carotid artery ligation and exposure to 8% oxygen for 15 min. The mice were allocated to an INI or control group (n = 8 in each group), receiving either 1.7 IU (17 µL) of insulin or saline intranasally. Infarct volume and neurological deficit scores (NDS) were also assessed. RNA sequencing was performed to identify potential genes and the signaling pathways involved.
ResultsCerebral infarction volumes did not differ between the two groups. NDS at 1 and 2 days following ischemic insult was lower in the INI group. However, no significant differences were observed after that. RNA sequencing analysis showed that the Oxt gene and neuronal pathways were upregulated in the INI group.
ConclusionINI improved behavioral symptoms temporarily, although cerebral infarct volume remained unchanged. As a possibility, the effects might be related to the Oxt gene expression.